Serum Institute of India

Activities: Manufacturing Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Serum Institute of India collaborates with Univercells to enhance availability of affordable personalised oncology

The partnership endeavours to speed up development times and distribute personalised cancer vaccines to all locations globally, rather than just economically developed countries
Infection Control

Oxford Ebola vaccine manufactured and shipped to Uganda

40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in 60 days
Packaging

Schott and Serum Institute of India announce joint venture

With this acquisition, Serum aims to secure its supply of pharma packaging amid rising global demand
Manufacturing

Genticel licenses Vaxiclase platform to Serum Institute of India for use in whooping cough vaccines

Agreement entitles Genticel to up to US$57m in upfront and milestones payments
Manufacturing

Cipla signs distribution agreement with Serum Institute of India

Enters the market for paediatric vaccines in Europe
Research & Development

Serum Institute of India acquires rights to TB vaccine

Researchers continue to refine classic BCG tuberculosis vaccine
Subscribe now